← Back to Search

Pulmonary Rehabilitation for Loneliness in COPD

N/A

Recruiting

Led By Dina Brooks, PhD

Research Sponsored by McMaster University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10 months

Awards & highlights

Study Summary

This trial will assess if pulmonary rehabilitation can help reduce loneliness in patients with chronic lung disease, improving their physical and mental health.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 10 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~10 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The University of California and Los Angeles Loneliness scale (UCLA-LS)

Secondary outcome measures

6-Minute Walk Test

Chronic Respiratory Disease Questionnaire (CRQ)

Generalized Anxiety Disorder - 7 (GAD - 7) Measure

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: COPD undergoing pulmonary rehabilitationExperimental Treatment1 Intervention

45 individuals with COPD will complete the UCLA-LS scale, CRQ, HADS, and 6 minute walk test before and after pulmonary rehabilitation.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Pulmonary rehabilitation (PR)

2014

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor

880 Previous Clinical Trials

2,597,783 Total Patients Enrolled

1 Trials studying Loneliness

Dina Brooks, PhDPrincipal InvestigatorMcMaster University

7 Previous Clinical Trials

538 Total Patients Enrolled

Media Library

Pulmonary rehabilitation (PR) Clinical Trial Eligibility Overview. Trial Name: NCT05435963 — N/A

Loneliness Research Study Groups: COPD undergoing pulmonary rehabilitation

Loneliness Clinical Trial 2023: Pulmonary rehabilitation (PR) Highlights & Side Effects. Trial Name: NCT05435963 — N/A

Pulmonary rehabilitation (PR) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05435963 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is the ideal demographic to participate in this scientific experiment?

"This clinical trial seeks a total of 45 lonely people aged between 18 and 100. Those that meet these criteria may be eligible to participate in the study."

Answered by AI

Is this research endeavor seeking out participants aged 50 and above?

"To qualify for this trial, participants must be between 18 and 100 years old. Separate studies have been commissioned to investigate the effects of this medication on individuals under 18 and those over 65 respectively, with 46 such trials currently in progress."

Answered by AI

Is enrollment open for this experiment?

"Yes, the info available on clinicaltrials.gov demonstrate that this experiment is still accepting participants. This trial was posted on January 23rd 2023 and has been edited for the last time on March 13th 2023. 45 people need to be recruited from one location."

Answered by AI

What is the current roster of participants for this therapeutic experiment?

"Affirmative. According to clinicaltrials.gov, this experiment is actively recruiting participants since it was first posted on January 23rd 2023 and last updated on March 13th 2023. It requires 45 individuals from a single site for participation."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Impact of Pulmonary Rehabilitation on Loneliness in COPD

2023. "Impact of Pulmonary Rehabilitation on Loneliness in COPD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05435963.